You must log in to view this page.

Kiora Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: KPRX
Share price (9/30/26): $2.56
Market cap (9/30/26): $11.3 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Exempt offering of securities

Registration of securities for employees

Shelf registration

Ownership Filter

Baselake Partners, LP

ADAR1 Capital Management, LLC

Nantahala Capital Management, LLC

News Filter

Appoints Keith J. Lane as Executive Vice President of Global Clinical Development and Regulatory Affairs

Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation

Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Reports Its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness